Skip to main content

Table 4 Prevalence of serogroups Uropathogenic E. coli

From: Biofilm formation, antimicrobial susceptibility, serogroups and virulence genes of uropathogenic E. coli isolated from clinical samples in Iran

Number of positive samples

Prevalence of serogroups (%)

O1

O2

O4

O6

O7

O8

O15

O16

O18

O21

O22

O25

O75

O83

High Biofilm Production E. coli (N = 15)

-

1 (6.66 %)

1 (6.66 %)

1 (6.66 %)

-

1 (6.66 %)

3 (20 %)

2 (13.33 %)

-

1 (6.66 %)

1 (6.66 %)

4 (26.66 %)

-

-

Moderate Biofilm Production E. coli (N = 20)

1 (5 %)

1 (5 %)

1 (5 %)

1 (5 %)

1 (5 %)

1 (5 %)

3 (15 %)

2 (10 %)

1 (5 %)

1 (5 %)

1 (5 %)

5 (25 %)

1

-

Weak Biofilm Production E. coli (N = 45)

1 (2.22 %)

1 (2.22 %)

2 (4.44 %)

6 (13.33 %)

1 (2.22 %)

1 (2.22 %)

10 (22.22 %)

5 (11.11 %)

1 (2.22 %)

2 (4.44 %)

1 (2.2 %)

13 (28.88 %)

1 (2.22 %)

-

No biofilm E. coli (N = 50)

1 (2 %)

1 (2 %)

3 (6 %)

8 (16 %)

2 (4 %)

1 (2 %)

11 (22 %)

1 (2 %)

1 (2 %)

4 (8 %)

1 (2 %)

14 (28 %)

1 (2 %)

1 (2 %)